- Home
- FEIM vs NVCT Comparison
FEIM vs NVCT Comparison
Compare FEIM & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEIM
- NVCT
- Stock Information
- Founded
- FEIM 1961
- NVCT 2020
- Country
- FEIM United States
- NVCT United States
- Employees
- FEIM N/A
- NVCT N/A
- Industry
- FEIM Electrical Products
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- FEIM Industrials
- NVCT Health Care
- Exchange
- FEIM Nasdaq
- NVCT Nasdaq
- Market Cap
- FEIM 173.6M
- NVCT 170.3M
- IPO Year
- FEIM N/A
- NVCT 2022
- Fundamental
- Price
- FEIM $15.65
- NVCT $9.77
- Analyst Decision
- FEIM
- NVCT Strong Buy
- Analyst Count
- FEIM 0
- NVCT 2
- Target Price
- FEIM N/A
- NVCT $15.00
- AVG Volume (30 Days)
- FEIM 64.0K
- NVCT 128.5K
- Earning Date
- FEIM 03-13-2025
- NVCT 05-06-2025
- Dividend Yield
- FEIM 6.52%
- NVCT N/A
- EPS Growth
- FEIM 604.98
- NVCT N/A
- EPS
- FEIM 2.41
- NVCT N/A
- Revenue
- FEIM $65,400,999.00
- NVCT N/A
- Revenue This Year
- FEIM N/A
- NVCT N/A
- Revenue Next Year
- FEIM N/A
- NVCT N/A
- P/E Ratio
- FEIM $6.44
- NVCT N/A
- Revenue Growth
- FEIM 24.10
- NVCT N/A
- 52 Week Low
- FEIM $8.62
- NVCT $4.44
- 52 Week High
- FEIM $20.33
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- FEIM 48.70
- NVCT 60.31
- Support Level
- FEIM $15.22
- NVCT $8.45
- Resistance Level
- FEIM $17.41
- NVCT $10.67
- Average True Range (ATR)
- FEIM 0.77
- NVCT 0.99
- MACD
- FEIM 0.08
- NVCT 0.08
- Stochastic Oscillator
- FEIM 52.69
- NVCT 72.98
About FEIM Frequency Electronics Inc.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.